Literature DB >> 25943916

Fluorescent Visualisation of Oxytocin in the Hypothalamo-neurohypophysial/-spinal Pathways After Chronic Inflammation in Oxytocin-Monomeric Red Fluorescent Protein 1 Transgenic Rats.

T Matsuura1,2, M Kawasaki2, H Hashimoto1, T Ishikura2, M Yoshimura1, J-I Ohkubo1, T Maruyama1, Y Motojima1,2, K Sabanai2, T Mori2, H Ohnishi2, A Sakai2, Y Ueta1.   

Abstract

Oxytocin (OXT) is a well-known neurohypophysial hormone that is synthesised in the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus. The projection of magnocellular neurosecretory cells, which synthesise OXT and arginine vasopressin in the PVN and SON, to the posterior pituitary plays an essential role in mammalian labour and lactation through its peripheral action. However, previous studies have shown that parvocellular OXTergic cells in the PVN, which project to the medulla and spinal cord, are involved in various physiological functions (e.g. sensory modulation and autonomic). In the present study, we examined OXT expression in the PVN, SON and spinal cord after chronic inflammation from adjuvant arthritis (AA). We used transgenic rats that express OXT and the monomeric red fluorescent protein 1 (mRFP1) fusion gene to visualise both the magnocellular and parvocellular OXTergic pathways. OXT-mRFP1 fluorescence intensity was significantly increased in the PVN, SON, dorsal horn of the spinal cord and posterior pituitary in AA rats. The levels of OXT-mRFP1 mRNA were significantly increased in the PVN and SON of AA rats. These results suggested that OXT was up-regulated in both hypothalamic magnocellular neurosecretory cells and parvocellular cells by chronic inflammation, and also that OXT in the PVN-spinal pathway may be involved in sensory modulation. OXT-mRFP1 transgenic rats are a very useful model for visualising the OXTergic pathways from vesicles in a single cell to terminals in in vitro preparations.
© 2015 British Society for Neuroendocrinology.

Entities:  

Keywords:  arthritic rats; chronic inflammation; fluorescent protein; oxytocin

Mesh:

Substances:

Year:  2015        PMID: 25943916     DOI: 10.1111/jne.12290

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  8 in total

1.  Possible involvement of central oxytocin in cisplatin-induced anorexia in rats.

Authors:  Koichi Arase; Hirofumi Hashimoto; Satomi Sonoda; Hiromichi Ueno; Reiko Saito; Yasuhito Motojima; Mitsuhiro Yoshimura; Takashi Maruyama; Keiji Hirata; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2017-06-14       Impact factor: 2.781

Review 2.  Oxytocin as a potential pharmacological tool to combat obesity.

Authors:  Pawel K Olszewski; Emily E Noble; Luis Paiva; Yoichi Ueta; James E Blevins
Journal:  J Neuroendocrinol       Date:  2022-02-22       Impact factor: 3.870

Review 3.  Approaches Mediating Oxytocin Regulation of the Immune System.

Authors:  Tong Li; Ping Wang; Stephani C Wang; Yu-Feng Wang
Journal:  Front Immunol       Date:  2017-01-10       Impact factor: 7.561

4.  Presynaptic glutamatergic transmission and feedback system of oxytocinergic neurons in the hypothalamus of a rat model of adjuvant arthritis.

Authors:  Teruaki Fujitani; Takanori Matsuura; Makoto Kawasaki; Hitoshi Suzuki; Haruki Nishimura; Kazuhiko Baba; Yoshiaki Yamanaka; Hideo Ohnishi; Yoichi Ueta; Akinori Sakai
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

5.  Expression of oxytocin in hypothalamus and reduction of nociceptive stress following administration of Kamikihi-to in female rats.

Authors:  Takashi Maruyama; Makiko Shimizu; Naofumi Ikeda; Kazuhiko Baba; Mitsuhiro Yoshimura; Yoichi Ueta
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

6.  Oestrogen-dependent hypothalamic oxytocin expression with changes in feeding and body weight in female rats.

Authors:  Kazuaki Nishimura; Kiyoshi Yoshino; Naofumi Ikeda; Kazuhiko Baba; Kenya Sanada; Yasuki Akiyama; Haruki Nishimura; Kentaro Tanaka; Satomi Sonoda; Hiromichi Ueno; Mitsuhiro Yoshimura; Takashi Maruyama; Toru Hachisuga; Yoichi Ueta
Journal:  Commun Biol       Date:  2022-09-05

7.  Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat.

Authors:  Kazuhiko Baba; Makoto Kawasaki; Haruki Nishimura; Hitoshi Suzuki; Takanori Matsuura; Naofumi Ikeda; Teruaki Fujitani; Yoshiaki Yamanaka; Manabu Tsukamoto; Hideo Ohnishi; Mitsuhiro Yoshimura; Takashi Maruyama; Kenya Sanada; Satomi Sonoda; Kazuaki Nishimura; Kentaro Tanaka; Tatsushi Onaka; Yoichi Ueta; Akinori Sakai
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

8.  Acute Mono-Arthritis Activates the Neurohypophysial System and Hypothalamo-Pituitary Adrenal Axis in Rats.

Authors:  Haruki Nishimura; Makoto Kawasaki; Takanori Matsuura; Hitoshi Suzuki; Yasuhito Motojima; Kazuhiko Baba; Hideo Ohnishi; Yoshiaki Yamanaka; Teruaki Fujitani; Mitsuhiro Yoshimura; Takashi Maruyama; Hiromichi Ueno; Satomi Sonoda; Kazuaki Nishimura; Kentarou Tanaka; Kenya Sanada; Tatsushi Onaka; Yoichi Ueta; Akinori Sakai
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-11       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.